Definium Therapeutics (DFTX) Long-Term Investments (2025)
Definium Therapeutics' (DFTX) quarterly Long-Term Investments came in at $54.9 million in Q2 2025, up 65.87% on a QoQ basis from $33.1 million in Q1 2025.
Definium Therapeutics (DFTX) Long-Term Investments (2025) Analysis & Trends
Definium Therapeutics (DFTX) has 1 years of Long-Term Investments data on file, last reported at $54.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 54.90 Mn |
| Mar 31, 2025 | 33.10 Mn |